Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Biological & Pharmaceutical Bulletin|March 8, 2026
Survey of Pharmacy Students' Awareness of Medication Overuse HeadacheShiori Yamada, Koki Takeda, Nobuhito Shibata, et al.Radiological Physics and Technology|May 23, 2024
Modulation transfer function of digital breast tomosynthesis: a comparison of various edge devicesTakashi Shirato, Kazuhiko Doryo, Shiori Yamada, et al.Current Alzheimer Research|March 12, 2019
Abnormal Saccadic Intrusions with Alzheimer's Disease in DarknessKiyotaka Nakamagoe, Shiori Yamada, Rio Kawakami, et al.Cancer Diagnosis & Prognosis|May 5, 2025
Factors Influencing Severe Hematologic Toxicity Following Niraparib Therapy in Patients With Ovarian CancerMichio Kimura, Shiori Yamada, Rina Matsuyama, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 5, 2023
Single-center survey of prescription trends and appropriate use plans for macrolide antimicrobialsTomoyuki Kato, Masayuki Nagasawa, Ippei Tanaka, et al.Oncology Letters|March 20, 2023
Evaluation of the therapeutic effects and tolerability of modified lenvatinib administration methods for unresectable hepatocellular carcinoma: A preliminary studyMichio Kimura, Makiko Go, Shiori Yamada, et al.Journal of Pharmacy Practice|April 23, 2024
Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive, HER2-Negative Metastatic/Recurrent Breast CancerMakiko Go, Michio Kimura, Shiori Yamada, et al.Current Alzheimer Research|March 25, 2021
Clinical Application of the Vestibular Stimulation Effect on Balance Disorders with DementiaKiyotaka Nakamagoe, Shiori Yamada, Rio Kawakami, et al.Oncology Letters|May 29, 2024
Safety evaluation of lenvatinib treatment after atezolizumab plus bevacizumab therapy for patients with unresectable liver cancer: A comparison of lenvatinib as 1st‑ or 2nd‑line treatmentMichio Kimura, Shiori Yamada, Makiko Go, et al.Cancer Diagnosis & Prognosis|March 4, 2024
Evaluation of Atezolizumab Plus Bevacizumab Versus Modified Lenvatinib Therapy in Child-Pugh A Unresectable Hepatocellular CarcinomaMichio Kimura, Shiori Yamada, Makiko Go, et al.Pageof 3